Endogenous secretory receptor for advanced glycation end products and chronic kidney disease in the elderly population.
Endogenous secretory receptor for advanced glycation end products and chronic kidney disease in the elderly population.
复制标题
老年人群中晚期糖基化终产物和慢性肾病的内源性分泌受体。
DOI：
10.1159/000324846
复制
发表时间：
2011
影响因子：
4.2
通讯作者：
Ferrucci,Luigi
中科院分区：
文献类型：
--
作者：
Dalal,Mansi;Semba,RichardD;Sun,Kai;Crasto,Candace;Varadhan,Ravi;Bandinelli,Stefania;Fink,JeffreyC;Guralnik,JackM;Ferrucci,Luigi
Background/Aims:The relationship of circulating endogenous secretory receptor for advanced glycation end products (esRAGE) and chronic kidney disease (CKD) has not been well characterized. The aim of the study was to determine whether plasma esRAGE is associated with CKD and is predictive of developing CKD in older adults.Methods:The relationship between plasma esRAGE and CKD (more than stage 3 of the National Kidney Foundation classification; estimated glomerular filtration rate <60 ml/min/1.73 m2) and CKD over 6 years of follow-up was examined in a cross-sectional and prospective study design in 1,016 men and women, ≧65 years, in the InCHIANTI study, a population-based cohort study of aging in Tuscany, Italy.Results:At enrollment, 158 (15.5%) had CKD. Mean (SD) plasma esRAGE was 0.45 (0.24) ng/ml. Plasma esRAGE (ng/ml) was associated with CKD (odds ratio per 1 SD = 1.30; 95% CI 1.1–1.6; p < 0.005) in a multivariable logistic regression model, adjusting for potential confounders. Plasma esRAGE was an independent predictor of incident CKD over 6 years of follow-up (hazard ratio per 1 SD = 1.37; 95% CI 1.1–1.7; p < 0.008) in a multivariable Cox proportional hazards model, adjusting for potential confounders.Conclusions:Elevated plasma esRAGE is independently associated with CKD and is an independent predictor of incident CKD in older community-dwelling adults.
